In study PROAB3006, seven cases (3%) were reported in 245 NRTI-experienced subjects treated with amprenavir and in 27 (11%) of 241 subjects treated with indinavir, in combination with various NRTIs for a median duration of 56 weeks (p < 0.001).
Uuringus PROAB3006 kirjeldati seitset juhtu (3%) 245 varem NRTI- ravi saanud patsiendi seas, keda raviti amprenaviiriga, ning 27 patsiendil (11%) 241- st, kes said raviks indinaviiri kombinatsioonis mitme NRTIga keskmiselt 56 nädala jooksul (p < 0, 001).